TRPV1 and lip and oral cavity carcinoma: In summary, the identification of TRPV1 and TRPA1 channels as biological targets to treat oral cancer pain, and chronic alcohol consumption as a confounding factor in patient-reported pain, which may mediate TRPV1 and TRPA1 activity, is critical to developing non-opioid drugs to treat oral cancer pain.